Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Om P Ganda

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Frontiers in Cardiovascular Medicine|March 31, 2025
Cross-Sectional analysis of demographic and clinical characteristics of patients in the United States using icosapent ethylPeter P Toth, John R Nelson, Handrean Soran, et al.
Archives of Internal Medicine|July 19, 2002
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trialScott M Grundy, Gloria Lena Vega, Mark E McGovern, et al.
The Lancet. Diabetes & Endocrinology|September 18, 2020
Diabetes in ageing: pathways for developing the evidence base for clinical guidanceMedha N Munshi, Graydon S Meneilly, Leocadio Rodríguez-Mañas, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Frontiers in Cardiovascular Medicine|March 31, 2025
Cross-Sectional analysis of demographic and clinical characteristics of patients in the United States using icosapent ethylPeter P Toth, John R Nelson, Handrean Soran, et al.
Archives of Internal Medicine|July 19, 2002
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trialScott M Grundy, Gloria Lena Vega, Mark E McGovern, et al.
The Lancet. Diabetes & Endocrinology|September 18, 2020
Diabetes in ageing: pathways for developing the evidence base for clinical guidanceMedha N Munshi, Graydon S Meneilly, Leocadio Rodríguez-Mañas, et al.
Pageof 3